• Nobritol Forte 25 mg/10 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  MEDAZEPAM	10 mg
  AMITRIPTYLINE HYDROCHLORide	25 mg

  ATC: N06C N06CA N06CA01

• Olanzapine Flas Kern Pharma 10 mg orodispersible tablets EFG

  Form: tablets, buccodispersable

  Active substance	Dosage
  OLANZAPINE	10,00 mg

  ATC: N05A N05AH N05AH03

• Olanzapine Flas Kern Pharma 15 mg orodispersible tablets EFG

  Form: tablets, buccodispersable

  Active substance	Dosage
  OLANZAPINE	15,00 mg

  ATC: N05A N05AH N05AH03

• Olanzapine Flas Kern Pharma 20 mg orodispersible tablets EFG

  Form: tablets, buccodispersable

  Active substance	Dosage
  OLANZAPINE	20,00 mg

  ATC: N05A N05AH N05AH03

• Olanzapine Flas Kern Pharma 5 mg orodispersible tablets EFG

  Form: tablets, buccodispersable

  Active substance	Dosage
  OLANZAPINE	5,00 mg

  ATC: N05A N05AH N05AH03

• Olanzapine Kern Pharma 10 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  OLANZAPINE	10 mg

  ATC: N05A N05AH N05AH03

• Olanzapine Kern Pharma 2.5 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  OLANZAPINE	2,5 mg

  ATC: N05A N05AH N05AH03

• Olanzapine Kern Pharma 5 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  OLANZAPINE	5 mg

  ATC: N05A N05AH N05AH03

• Olanzapine Kern Pharma 7.5 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  OLANZAPINE	7,5 mg

  ATC: N05A N05AH N05AH03

• Olmesartan Kern Pharma 10 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  OLMESARTAN MEDOXOMIL	10 mg

  ATC: C09C C09CA C09CA08

• Olmesartan Kern Pharma 20 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  OLMESARTAN MEDOXOMIL	20 mg

  ATC: C09C C09CA C09CA08

• Olmesartan Kern Pharma 40 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  OLMESARTAN MEDOXOMIL	40 mg

  ATC: C09C C09CA C09CA08

• Olmesartan/amlodipine Kern Pharma 20 mg/5 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  OLMESARTAN MEDOXOMIL	20 mg
  AMLODIPINE BESYLATE	6,95 mg

  ATC: C09D C09DB C09DB02

• Olmesartan/amlodipine Kern Pharma 40 mg/10 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  OLMESARTAN MEDOXOMIL	40 mg
  AMLODIPINE BESYLATE	13,90 mg

  ATC: C09D C09DB C09DB02

• Olmesartan/amlodipine Kern Pharma 40 mg/5 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  OLMESARTAN MEDOXOMIL	40 mg
  AMLODIPINE BESYLATE	6,95 mg

  ATC: C09D C09DB C09DB02

• Olmesartan/amlodipine/hydrochlorothiazide Kern Pharma 20 mg/5 mg/12.5 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  OLMESARTAN MEDOXOMIL	20 mg
  AMLODIPINE BESYLATE	6,934 mg
  HYDROCHLOROTHIAZIDE	12,5 mg

  ATC: C09D C09DX C09DX03

• Olmesartan/amlodipine/hydrochlorothiazide Kern Pharma 40 mg/10 mg/12.5 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  OLMESARTAN MEDOXOMIL	40 mg
  AMLODIPINE BESYLATE	13,868 mg
  HYDROCHLOROTHIAZIDE	12,5 mg

  ATC: C09D C09DX C09DX03

• Olmesartan/amlodipine/hydrochlorothiazide Kern Pharma 40 mg/10 mg/25 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  OLMESARTAN MEDOXOMIL	40 mg
  AMLODIPINE BESYLATE	13,868 mg
  HYDROCHLOROTHIAZIDE	25 mg

  ATC: C09D C09DX C09DX03

• Olmesartan/amlodipine/hydrochlorothiazide Kern Pharma 40 mg/5 mg/12.5 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  OLMESARTAN MEDOXOMIL	40 mg
  AMLODIPINE BESYLATE	6,934 mg
  HYDROCHLOROTHIAZIDE	12,5 mg

  ATC: C09D C09DX C09DX03

• Olmesartan/amlodipine/hydrochlorothiazide Kern Pharma 40 mg/5 mg/25 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  OLMESARTAN MEDOXOMIL	40 mg
  AMLODIPINE BESYLATE	6,93 mg
  HYDROCHLOROTHIAZIDE	25 mg

  ATC: C09D C09DX C09DX03

• Olmesartan/hydrochlorothiazide Kern Pharma 20 mg/12.5 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  OLMESARTAN MEDOXOMIL	20 mg
  HYDROCHLOROTHIAZIDE	12,5 mg

  ATC: C09D C09DA C09DA08

• Olmesartan/hydrochlorothiazide Kern Pharma 20 mg/25 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  OLMESARTAN MEDOXOMIL	20 mg
  HYDROCHLOROTHIAZIDE	25 mg

  ATC: C09D C09DA C09DA08

• Olmesartan/hydrochlorothiazide Kern Pharma 40 mg/12.5 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  OLMESARTAN MEDOXOMIL	40 mg
  HYDROCHLOROTHIAZIDE	12,5 mg

  ATC: C09D C09DA C09DA08

• Olmesartan/hydrochlorothiazide Kern Pharma 40 mg/25 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  OLMESARTAN MEDOXOMIL	40 mg
  HYDROCHLOROTHIAZIDE	25 mg

  ATC: C09D C09DA C09DA08

• Omega-3 fatty acids Kern Pharma 1.000 mg soft capsules EFG

  Form: capsules, soft gelatin

  Active substance	Dosage
  OMEGA 3 ETHYL ESTERS ACIDS	1.000 mg

  ATC: C10A C10AX C10AX06

• Omeprazole Healthkern 20 mg gastro-resistant hard capsules

  Form: capsules, hard, enteric-coated

  Active substance	Dosage
  OMEPRAZOLE	20 mg

  ATC: A02B A02BC A02BC01

• Omeprazole Kern Pharma 20 mg gastro-resistant hard capsules EFG

  Form: capsules, hard, enteric-coated

  Active substance	Dosage
  OMEPRAZOLE	20 mg

  ATC: A02B A02BC A02BC01

• Omeprazole Kern Pharma 40 mg gastro-resistant hard capsules

  Form: capsules, hard, enteric-coated

  Active substance	Dosage
  OMEPRAZOLE	40 mg

  ATC: A02B A02BC A02BC01

• Palgesic Retard 100 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  TAPENTADOL PHOSPHATE	153,13 mg

  ATC: N02A N02AX N02AX06

• Palgesic Retard 150 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  TAPENTADOL PHOSPHATE	229,70 mg

  ATC: N02A N02AX N02AX06

• Palgesic Retard 200 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  TAPENTADOL PHOSPHATE	306,27 mg

  ATC: N02A N02AX N02AX06

• Palgesic Retard 25 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  TAPENTADOL PHOSPHATE	38,28 mg

  ATC: N02A N02AX N02AX06

• Palgesic Retard 250 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  TAPENTADOL PHOSPHATE	382,84 mg

  ATC: N02A N02AX N02AX06

• Palgesic Retard 50 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  TAPENTADOL PHOSPHATE	76,57 mg

  ATC: N02A N02AX N02AX06

• Pantoprazole Kern Pharma 20 mg gastro-resistant tablets EFG

  Form: tablets, enteric-coated

  Active substance	Dosage
  PANTOPRAZOLE SODIUM	22,550 mg

  ATC: A02B A02BC A02BC02

• Pantoprazole Kern Pharma 40 mg gastro-resistant tablets EFG

  Form: tablets, enteric-coated

  Active substance	Dosage
  PANTOPRAZOLE SODIUM	45,10 mg

  ATC: A02B A02BC A02BC02

• Paracetamol Kern Pharma 1 g tablets EFG

  Form: tablets

  Active substance	Dosage
  PARACETAMOL	90 %

  ATC: N02B N02BE N02BE01

• Paracetamol Kern Pharma 100 mg/ml oral solution EFG

  Form: solution, oral

  Active substance	Dosage
  PARACETAMOL	100,0 mg

  ATC: N02B N02BE N02BE01

• Paracetamol Kern Pharma 500 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  PARACETAMOL	500 mg

  ATC: N02B N02BE N02BE01

• Paracetamol Kern Pharma 650 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  PARACETAMOL	650 mg

  ATC: N02B N02BE N02BE01

• Paracetamol/codeine Kern Pharma 500 mg/30 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  PARACETAMOL	500 mg
  CODEINE PHOSPHATE HEMIHYDRATE	30 mg

  ATC: N02A N02AJ N02AJ06

• Paroxetine Kern Pharma 20 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  PAROXETINE HYDROCHLORIDE HEMIHYDRATE	22,76 mg

  ATC: N06A N06AB N06AB05

• Pirfenidone Kern Pharma 267 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  PIRFENIDONE	267 mg

  ATC: L04A L04AX L04AX05

• Pirfenidone Kern Pharma 801 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  PIRFENIDONE	801 mg

  ATC: L04A L04AX L04AX05

• Pitavastatin Kern Pharma 1 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  PITAVASTATIN CALCIUM	1,045 mg

  ATC: C10A C10AA C10AA08

• Pitavastatin Kern Pharma 2 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  PITAVASTATIN CALCIUM	2,09 mg

  ATC: C10A C10AA C10AA08

• Pitavastatin Kern Pharma 4 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  PITAVASTATIN CALCIUM	4,18 mg

  ATC: C10A C10AA C10AA08

• Pramipexole Kern Pharma 0.18 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  PRAMIPEXOL	0,18 mg

  ATC: N04B N04BC N04BC05

• Pramipexole Kern Pharma 0.26 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  Pramipexole Dihydrochloride Monohydrate	0,375 mg

  ATC: N04B N04BC N04BC05

• Pramipexole Kern Pharma 0.7 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  PRAMIPEXOL	0,7 mg

  ATC: N04B N04BC N04BC05